Search Results

Janet Vaughn has worked in pharmaceutical regulatory affairs for nearly 30 years more than 20 of them at Teva In December 2020 Janet was appointed Head of Regulatory Affairs for Teva s North America Generics business One in ten of the 3 66 billion generic prescriptions written in the United States is filled with a Teva product 1 and the company manufactures more than 500 generic prescription and over the counter products in more than 2 000 dosage strengths and package sizes including oral solid dosage forms injectable products inhaled products liquids ointments and creams 2 Leading the team responsible for regulatory affairs for one of the largest and most diversified generics portfolios in the industry Janet explains the importance of building relationships and what separates great leaders from good ones

We explain why generic medicines are an essential part of modern healthcare and look at the research development processes and logistical challenges involved in creating them